Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A5XY
|
|||
| Former ID |
DNC011209
|
|||
| Drug Name |
N-(2-bromobenzoyloxy)-4-chlorobenzamide
|
|||
| Synonyms |
CHEMBL1253383; N-{[(2-bromophenyl)carbonyl]oxy}-4-chlorobenzamide; N-(2-bromobenzoyloxy)-4-chlorobenzamide; AC1LQE9K; CBMicro_012071; MolPort-002-189-016; ZINC1186119; SMSF0017521; STK185858; BDBM50326572; AKOS005412260; MCULE-4091237725; CB15272; [(4-chlorobenzoyl)amino] 2-bromobenzoate; BIM-0012056.P001; SR-01000230575
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H9BrClNO3
|
|||
| Canonical SMILES |
C1=CC=C(C(=C1)C(=O)ONC(=O)C2=CC=C(C=C2)Cl)Br
|
|||
| InChI |
1S/C14H9BrClNO3/c15-12-4-2-1-3-11(12)14(19)20-17-13(18)9-5-7-10(16)8-6-9/h1-8H,(H,17,18)
|
|||
| InChIKey |
XBZVDYJKCJLDSB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | MIF messenger RNA (MIF mRNA) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Tyrosine metabolism | |||
| Phenylalanine metabolism | ||||
| Pathwhiz Pathway | Tyrosine Metabolism | |||
| WikiPathways | Spinal Cord Injury | |||
| Adipogenesis | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem. 2010 Jul 15;18(14):5425-40. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.